OSR (NASDAQ:OSRH) Posts Quarterly Earnings Results

OSR (NASDAQ:OSRH) issued its quarterly earnings results on Wednesday. The company reported ($0.10) EPS for the quarter, Zacks reports.

OSR Stock Up 4.8%

OSRH opened at $0.59 on Thursday. The company has a market cap of $12.73 million, a P/E ratio of -0.58 and a beta of 1.41. The firm’s 50-day moving average price is $0.62 and its 200-day moving average price is $0.94. OSR has a 52-week low of $0.45 and a 52-week high of $13.40.

Wall Street Analyst Weigh In

Several research firms recently commented on OSRH. Weiss Ratings reaffirmed a “sell (d)” rating on shares of OSR in a research note on Wednesday, October 8th. Wall Street Zen raised shares of OSR to a “sell” rating in a research note on Saturday, October 18th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, OSR has a consensus rating of “Sell”.

OSR Company Profile

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials.